Cargando…

Risk factors for pneumonia in patients with schizophrenia

AIM: Pneumonia is a major cause of death in patients with schizophrenia. Preventive strategies based on identifying the risk factors are needed to reduce pneumonia‐related mortality. This study aimed to clarify the risk factors for pneumonia in patients with schizophrenia. METHODS: We retrospectivel...

Descripción completa

Detalles Bibliográficos
Autores principales: Haga, Takahiro, Ito, Kae, Sakashita, Kentaro, Iguchi, Mari, Ono, Masahiro, Tatsumi, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292272/
https://www.ncbi.nlm.nih.gov/pubmed/30353691
http://dx.doi.org/10.1002/npr2.12034
_version_ 1783546076795502592
author Haga, Takahiro
Ito, Kae
Sakashita, Kentaro
Iguchi, Mari
Ono, Masahiro
Tatsumi, Koichiro
author_facet Haga, Takahiro
Ito, Kae
Sakashita, Kentaro
Iguchi, Mari
Ono, Masahiro
Tatsumi, Koichiro
author_sort Haga, Takahiro
collection PubMed
description AIM: Pneumonia is a major cause of death in patients with schizophrenia. Preventive strategies based on identifying the risk factors are needed to reduce pneumonia‐related mortality. This study aimed to clarify the risk factors for pneumonia in patients with schizophrenia. METHODS: We retrospectively reviewed the clinical files of consecutive patients with schizophrenia admitted to Tokyo Metropolitan Matsuzawa Hospital during a four‐year period from January 2014 to December 2017. We analyzed the clinical differences between patients with and without pneumonia. RESULTS: Of the 2209 patients enrolled, 101 (4.6%) received the diagnosis of pneumonia at the time of hospital admission while 2108 (95.4%) did not have pneumonia. Multivariable analysis to determine the risk factors related to pneumonia showed that the use of atypical antipsychotics had the highest odds ratio among the predictive factors (2.7; 95% confidence interval [CI] 1.0‐17.7; P = 0.046), followed by a total chlorpromazine equivalent dose ≥600 mg (2.6; 95% CI 1.7‐4.0; P < 0.001), body mass index <18.5 kg/m(2) (2.3; 95% CI 1.6‐3.6; P < 0.001), smoking history (2.0; 95% CI 1.3‐3.1; P < 0.001), and age ≥50 years (1.7; 95% CI 1.2‐2.6; P = 0.002). CONCLUSIONS: We found that advanced age, underweight, smoking habit, use of atypical antipsychotics, and large doses of antipsychotics were risk factors for pneumonia in patients with schizophrenia. Among these factors, it was unclear whether the use of antipsychotics was a direct cause of pneumonia due to is uncertain because our retrospective study design. However, our result might be a good basis of further study focused on reducing pneumonia‐related fatalities in schizophrenic patients with pneumonia.
format Online
Article
Text
id pubmed-7292272
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-72922722020-12-08 Risk factors for pneumonia in patients with schizophrenia Haga, Takahiro Ito, Kae Sakashita, Kentaro Iguchi, Mari Ono, Masahiro Tatsumi, Koichiro Neuropsychopharmacol Rep Original Articles AIM: Pneumonia is a major cause of death in patients with schizophrenia. Preventive strategies based on identifying the risk factors are needed to reduce pneumonia‐related mortality. This study aimed to clarify the risk factors for pneumonia in patients with schizophrenia. METHODS: We retrospectively reviewed the clinical files of consecutive patients with schizophrenia admitted to Tokyo Metropolitan Matsuzawa Hospital during a four‐year period from January 2014 to December 2017. We analyzed the clinical differences between patients with and without pneumonia. RESULTS: Of the 2209 patients enrolled, 101 (4.6%) received the diagnosis of pneumonia at the time of hospital admission while 2108 (95.4%) did not have pneumonia. Multivariable analysis to determine the risk factors related to pneumonia showed that the use of atypical antipsychotics had the highest odds ratio among the predictive factors (2.7; 95% confidence interval [CI] 1.0‐17.7; P = 0.046), followed by a total chlorpromazine equivalent dose ≥600 mg (2.6; 95% CI 1.7‐4.0; P < 0.001), body mass index <18.5 kg/m(2) (2.3; 95% CI 1.6‐3.6; P < 0.001), smoking history (2.0; 95% CI 1.3‐3.1; P < 0.001), and age ≥50 years (1.7; 95% CI 1.2‐2.6; P = 0.002). CONCLUSIONS: We found that advanced age, underweight, smoking habit, use of atypical antipsychotics, and large doses of antipsychotics were risk factors for pneumonia in patients with schizophrenia. Among these factors, it was unclear whether the use of antipsychotics was a direct cause of pneumonia due to is uncertain because our retrospective study design. However, our result might be a good basis of further study focused on reducing pneumonia‐related fatalities in schizophrenic patients with pneumonia. John Wiley and Sons Inc. 2018-10-23 /pmc/articles/PMC7292272/ /pubmed/30353691 http://dx.doi.org/10.1002/npr2.12034 Text en © 2018 The Authors. Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Neuropsychopharmacology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Haga, Takahiro
Ito, Kae
Sakashita, Kentaro
Iguchi, Mari
Ono, Masahiro
Tatsumi, Koichiro
Risk factors for pneumonia in patients with schizophrenia
title Risk factors for pneumonia in patients with schizophrenia
title_full Risk factors for pneumonia in patients with schizophrenia
title_fullStr Risk factors for pneumonia in patients with schizophrenia
title_full_unstemmed Risk factors for pneumonia in patients with schizophrenia
title_short Risk factors for pneumonia in patients with schizophrenia
title_sort risk factors for pneumonia in patients with schizophrenia
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292272/
https://www.ncbi.nlm.nih.gov/pubmed/30353691
http://dx.doi.org/10.1002/npr2.12034
work_keys_str_mv AT hagatakahiro riskfactorsforpneumoniainpatientswithschizophrenia
AT itokae riskfactorsforpneumoniainpatientswithschizophrenia
AT sakashitakentaro riskfactorsforpneumoniainpatientswithschizophrenia
AT iguchimari riskfactorsforpneumoniainpatientswithschizophrenia
AT onomasahiro riskfactorsforpneumoniainpatientswithschizophrenia
AT tatsumikoichiro riskfactorsforpneumoniainpatientswithschizophrenia